AAAAAA

   
Results: 1-9 |
Results: 9
Allogeneic cell therapy for patients who relapse after autologous stem cell transplantation
Authors: Porter, DL Luger, SM Duffy, KM Stadtmauer, EA Laport, G Schuster, SJ Orloff, G Tsai, D McDaid, K Kathakali, A Leonard, DGB Antin, JH
Citation: Dl. Porter et al., Allogeneic cell therapy for patients who relapse after autologous stem cell transplantation, BIOL BLOOD, 7(4), 2001, pp. 230-238
Nuclear factor-kappa B is constitutively activated in primitive human acute myelogenous leukemia cells
Authors: Guzman, ML Neering, SJ Upchurch, D Grimes, B Howard, DS Rizzieri, DA Luger, SM Jordan, CT
Citation: Ml. Guzman et al., Nuclear factor-kappa B is constitutively activated in primitive human acute myelogenous leukemia cells, BLOOD, 98(8), 2001, pp. 2301-2307
Sudden death among patients with acute promyelocytic leukemia treated witharsenic trioxide
Authors: Westervelt, P Brown, RA Adkins, DR Khoury, H Curtin, P Hurd, D Luger, SM Ma, MK Ley, TJ DiPersio, JF
Citation: P. Westervelt et al., Sudden death among patients with acute promyelocytic leukemia treated witharsenic trioxide, BLOOD, 98(2), 2001, pp. 266-271
Expression of tumor-suppressor genes interferon regulatory factor 1 and death-associated protein kinase in primitive acute myelogenous leukemia cells
Authors: Guzman, ML Upchurch, D Grimes, B Howard, DS Rizzieri, DA Luger, SM Phillips, GL Jordan, CT
Citation: Ml. Guzman et al., Expression of tumor-suppressor genes interferon regulatory factor 1 and death-associated protein kinase in primitive acute myelogenous leukemia cells, BLOOD, 97(7), 2001, pp. 2177-2179
The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells
Authors: Jordan, CT Upchurch, D Szilvassy, SJ Guzman, ML Howard, DS Pettigrew, AL Meyerrose, T Rossi, R Grimes, B Rizzieri, DA Luger, SM Phillips, GL
Citation: Ct. Jordan et al., The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells, LEUKEMIA, 14(10), 2000, pp. 1777-1784
Effect of postremission chemotherapy before human leukocyte antigen-identical sibling transplantation for acute myelogenous leukemia in first complete remission
Authors: Tallman, MS Rowlings, PA Milone, G Zhang, MJ Perez, WS Weisdorf, D Keating, A Gale, RP Geller, RB Laughlin, MJ Lazarus, HM Luger, SM McCarthy, PL Rowe, JM Saez, RA Vowels, MR Horowitz, MM
Citation: Ms. Tallman et al., Effect of postremission chemotherapy before human leukocyte antigen-identical sibling transplantation for acute myelogenous leukemia in first complete remission, BLOOD, 96(4), 2000, pp. 1254-1258
What is the role of autologous stem cell transplantation for leukemia?
Authors: Luger, SM Stadtmauer, EA
Citation: Sm. Luger et Ea. Stadtmauer, What is the role of autologous stem cell transplantation for leukemia?, CUR CLIN ON, 2000, pp. 119-135
Stem cell transplantation for metastatic breast cancer: analysis of tumor contamination
Authors: Stadtmauer, EA Tsai, DE Sickles, CJ Mick, R Luger, SM Porter, DL Mangan, PA Schuchter, LM Schuster, SJ Loh, EY Magee, DA Sachs, RA Wall, ME Moore, J Buzby, GP Zaleta, E Kamoun, M Silberstein, LE
Citation: Ea. Stadtmauer et al., Stem cell transplantation for metastatic breast cancer: analysis of tumor contamination, MED ONCOL, 16(4), 1999, pp. 279-288
Autologous stem-cell transplant after conventional dose adjuvant chemotherapy for high-risk breast cancer: Impact on the delivery of local-regional radiation therapy
Authors: Moore, HCF Mick, R Solin, LJ Sickles, C Mangan, PA Luger, SM Fox, KR Schuchter, LM Loh, E Porter, DL Schuster, S Buzby, GP Glatstein, E Silberstein, LE Stadtmauer, EA
Citation: Hcf. Moore et al., Autologous stem-cell transplant after conventional dose adjuvant chemotherapy for high-risk breast cancer: Impact on the delivery of local-regional radiation therapy, ANN ONCOL, 10(8), 1999, pp. 929-936
Risultati: 1-9 |